Cowtown Angels
VC Fund
Fort Worth, United States
Cowtown Angels is a VC fund in Fort Worth focused on Health Care and Therapeutics. Cowtown Angels dual motive falls into helping young businesses get connected with local angel investors with the goal of creating more jobs and wealth in our local community. Cowtown Angels not only introduces the angels to the entrepreneurs, it also plans to coach those entrepreneurs through the process of securing funding. The program is one ofthe newest and fastest growing of the ACA. It is based in Fort Worth, Texas and founded by TECH Forth Worth, a non-profit organization created by the City of Fort Worth in 1998 to drive economic development through the generation of technology startups.
- Total investments:
- 11
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Cowtown Angels invests in
Stages Cowtown Angels invests in
Countries Cowtown Angels invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Ryan Brown
|
|||
4 more contacts available
Investment Focus
Industry
- Health Care 3 (27%)
- Therapeutics 3 (27%)
- Life Science 2 (18%)
- Biotechnology 2 (18%)
- Baby 1 (9%)
Stage
- Seed 3 (27%)
- Series B 3 (27%)
- Series A 2 (18%)
- Angel 1 (9%)
- Pre-Seed 1 (9%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Ryan Brown
CEO
|
CEO | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Green Steel Environmental
|
Developer of sustainable clean products designed to clean hydrogen sulfide into renewable gas. The company uses clean tech upcycled materials to remove excess nutrients from wastewater and renewable natural gas, enabling returns of those nutrients to the earth as fertilizer. | $1.7M / Seed / Aug 07, 2025 | |
Smart Response Technologies
|
Smart Response Technologies is a technology company developing transformative AI. | $1.6M / Seed / Mar 03, 2024 | |
VenoStent
|
VenoStent is a clinical-stage tissue engineering company that’s developed tunable, bioabsorbable smart polymer wraps in order to fundamentally transform the 5 million vascular surgeries performed each year. | $16M / Series A / Jul 31, 2023 | |
Zylö Therapeutics
|
Zylö Therapeutics offers an innovative sustained-release drug-delivery system that was developed by Joel Friedman MD PhD, Adam Friedman MD FAAD, and Andrew Draganski PhD. The delivery system uses patented hydrogel-derived nanoparticles, called Nanopods, to deliver—in a sustained and controlled manner—notoriously hard-to-deliver therapeutic agentsthrough topical administration.The company was founded in 2017 and is based in Greenville, South Carolina. | $5.2M / Series B / Jun 03, 2022 | |
|
VenoStent
|
VenoStent is a clinical-stage tissue engineering company that’s developed tunable, bioabsorbable smart polymer wraps in order to fundamentally transform the 5 million vascular surgeries performed each year. | $3M / Seed / Feb 23, 2021 | |
|
VenoStent
|
VenoStent is a clinical-stage tissue engineering company that’s developed tunable, bioabsorbable smart polymer wraps in order to fundamentally transform the 5 million vascular surgeries performed each year. | $535K / Seed / Apr 26, 2020 | |
Tot Squad
|
Tot Squad is a marketplace that connects new parents with health, wellness and safety services both virtually and in person. We're a one-stop shop in the $46B "New Mom Economy" consolidating the highly fragmented providers of services like car seat installation, babyproofing, and lactation consulting. Our car seat installationservices can be found on Amazon and Walmart as an add-on with a car seat purchase. | $2.5M / Pre-Seed / Mar 31, 2017 | |
Cognition Therapeutics
|
Cognition Therapeutics, Inc. is focused on the discovery and development of small molecule therapeutics targeting the toxic proteins that cause the cognitive decline associated with Alzheimer's disease and other degenerative diseases of the human brain. Toxic proteins play a crucial role in a large class of disease targets, and there arecurrently no therapeutics available to prevent toxic protein accumulation or block their destructive effects. Cognition is founded on the unique combination of biological expertise around these targets, including proprietary assays that emphasize functional responses and proprietary medicinal chemistry that insures novel, high quality small-molecule drug candidates. | $12M / Series B / Sep 08, 2015 | |
Wisegate
|
Wisegate is a practitioner-based IT research service that lets qualified senior IT professionals freely share information without the influence of analysts, vendors, media or advertisers - like a crowd-sourced version of Gartner, but no vendors allowed.Using a crowdsourcing model and advanced algorithms, Wisegate gives senior technologyprofessionals trusted, timely and relevant access to the most authentic intelligence about IT: the collective knowledge and experience of their peers. Wisegate offers honest, pragmatic information and advice based on the real-world experiences of veteran IT professionals. No analyst theories or vendor bias; just clear and straightforward insight directly from experienced technology leaders. | $4M / Series B / Dec 16, 2014 | |
Encore Vision
|
Encore Vision is developing a technology for the treatment of presbyopia. The company has been well-financed and mentored by ophthalmologists and optometrists during its incubation phase. Encore Vision has achieved significant progress in developing extensive Intellectual Property protection. Encore Vision’s technology is covered by a robust andgrowing patent portfolio which includes one issued broad-based US patent, a notice of allowance on a second U.S. patent, and more than 40 Pending the US and foreign patent applications and provisional filings, including the composition of matter applications for its proprietary formulations. The company has completed in-vivo proof of concept in an animal model for presbyopia and has begun development activities leading to clinical studies in man.It was established in 2000 and is headquartered in Fort Worth, Texas. | $5M / Angel / Dec 19, 2013 | |
| See all 11 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Cowtown Angels invest in?
Cowtown Angels invests primarily in Health Care, Therapeutics and Life Science startups, most often at Seed and Series B stage. Most of the 11 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Cowtown Angels?
Public channels for Cowtown Angels include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Cowtown Angels?
The team at Cowtown Angels includes Ryan Brown (CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
